Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $502.1900 (1.39%) ($502.1900 - $505.8500) on Fri. May. 28, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.52% (three month average) | RSI | 52 | Latest Price | $502.1900(1.39%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN declines -0.2% a day on average for past five trading days. | Weekly Trend | REGN declines -1.2% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(52%) XLV(42%) DIA(36%) SPLV(36%) IVW(35%) | Factors Impacting REGN price | REGN will decline at least -0.76% in a week (0% probabilities). VIXM(-21%) TBT(-7%) UUP(-6%) VXX(-5%) USO(-0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.76% (StdDev 1.52%) | Hourly BBV | 1 () | Intraday Trend | 0% | | | |
|
Resistance Level | $502.91 | 5 Day Moving Average | $498.28(0.78%) | 10 Day Moving Average | $505.7(-0.69%) | 20 Day Moving Average | $502.91(-0.14%) | To recent high | -4.1% | To recent low | 12.4% | Market Cap | $53.247b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |